Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Trends in Use of Medical Imaging in US Health Care Systems and in Ontario, Canada, 2000-2016.

Smith-Bindman R, Kwan ML, Marlow EC, Theis MK, Bolch W, Cheng SY, Bowles EJA, Duncan JR, Greenlee RT, Kushi LH, Pole JD, Rahm AK, Stout NK, Weinmann S, Miglioretti DL.

JAMA. 2019 Sep 3;322(9):843-856. doi: 10.1001/jama.2019.11456.

PMID:
31479136
2.

Decision Regret Related to Urinary Diversion Choice Among Cystectomy Patients.

Check DK, Leo MC, Banegas MP, Bulkley JE, Danforth KN, Gilbert SM, Kwan ML, O'Keeffe Rosetti M, McMullen CK.

J Urol. 2019 Aug 23:101097JU0000000000000512. doi: 10.1097/JU.0000000000000512. [Epub ahead of print]

PMID:
31441673
3.

Trends in Medical Imaging During Pregnancy in the United States and Ontario, Canada, 1996 to 2016.

Kwan ML, Miglioretti DL, Marlow EC, Aiello Bowles EJ, Weinmann S, Cheng SY, Deosaransingh KA, Chavan P, Moy LM, Bolch WE, Duncan JR, Greenlee RT, Kushi LH, Pole JD, Rahm AK, Stout NK, Smith-Bindman R; Radiation-Induced Cancers Study Team.

JAMA Netw Open. 2019 Jul 3;2(7):e197249. doi: 10.1001/jamanetworkopen.2019.7249.

4.

SeqSQC: A Bioconductor Package for Evaluating the Sample Quality of Next-generation Sequencing Data.

Liu Q, Hu Q, Yao S, Kwan ML, Roh JM, Zhao H, Ambrosone CB, Kushi LH, Liu S, Zhu Q.

Genomics Proteomics Bioinformatics. 2019 Apr;17(2):211-218. doi: 10.1016/j.gpb.2018.07.006. Epub 2019 Apr 5.

5.

Germline Genetic Variants in GATA3 and Breast Cancer Treatment Outcomes in SWOG S8897 Trial and the Pathways Study.

Larsen V, Barlow WE, Yang JJ, Zhu Q, Liu S, Kwan ML, Ergas IJ, Roh JM, Hutchins LF, Kadlubar SA, Albain KS, Rae JM, Yeh IT, Ravdin PM, Martino S, Lyss AP, Osborne CK, Hortobagyi GN, Kushi LH, Hayes DF, Ambrosone CB, Yao S.

Clin Breast Cancer. 2019 Aug;19(4):225-235.e2. doi: 10.1016/j.clbc.2019.02.010. Epub 2019 Mar 6.

PMID:
30928413
6.

Early-onset triple-negative breast cancer in multiracial/ethnic populations: Distinct trends of prevalence of truncation mutations.

Liu Q, Yao S, Zhao H, Hu Q, Kwan ML, Roh JM, Ambrosone CB, Kushi LH, Liu S, Zhu Q.

Cancer Med. 2019 Apr;8(4):1845-1853. doi: 10.1002/cam4.2047. Epub 2019 Mar 12.

7.

Recovering from Cystectomy: Patient Perspectives.

McMullen CK, Kwan ML, Colwell JC, Munneke JR, Davis JV, Firemark A, Brooks N, Grant M, Gilbert SM, Altschuler A.

Bladder Cancer. 2019 Jan 31;5(1):51-61. doi: 10.3233/BLC-180202.

8.

The association of medical and demographic characteristics with sarcopenia and low muscle radiodensity in patients with nonmetastatic colorectal cancer.

Xiao J, Caan BJ, Cespedes Feliciano EM, Meyerhardt JA, Kroenke CH, Baracos VE, Weltzien E, Kwan ML, Alexeeff SE, Castillo AL, Prado CM.

Am J Clin Nutr. 2019 Mar 1;109(3):615-625. doi: 10.1093/ajcn/nqy328.

PMID:
30850836
9.

Development of a Goal Elicitation Measure to Support Choice about Urinary Diversion by Patients with Bladder Cancer.

Leo MC, Gilbert SM, Wendel CS, Krouse RS, Grant M, Danforth KN, Kwan ML, Harrison TN, Bulkley JE, McMullen CK.

J Urol. 2019 Jul;202(1):83-89. doi: 10.1097/JU.0000000000000203. Epub 2019 Jun 7.

PMID:
30835627
10.

AUTHOR REPLY.

Kwan ML, Danforth KN, Aaronson DS, Wagner MD, Williams SG, McMullen CK.

Urology. 2019 Mar;125:229. doi: 10.1016/j.urology.2018.11.023. No abstract available.

PMID:
30798971
11.

The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer.

Kwan ML, Kushi LH, Danforth KN, Roh JM, Ergas IJ, Lee VS, Cannavale KL, Harrison TN, Contreras R, Loo RK, Aaronson DS, Quesenberry CP, Tritchler D, Ghai NR, Quinn VP, Ambrosone CB, Zhang Y, Tang L.

Cancer Causes Control. 2019 Feb;30(2):187-193. doi: 10.1007/s10552-019-1130-8. Epub 2019 Jan 17.

PMID:
30656539
12.

Opportunities to Improve Detection and Treatment of Depression Among Patients With Breast Cancer Treated in an Integrated Delivery System.

Check DK, Kwan ML, Chawla N, Dusetzina SB, Valice E, Ergas IJ, Roh JM, Kolevska T, Rosenstein DL, Kushi LH.

J Pain Symptom Manage. 2019 Mar;57(3):587-595. doi: 10.1016/j.jpainsymman.2018.11.024. Epub 2018 Dec 1.

PMID:
30508637
13.

Factors That Influence Selectionof Urinary Diversion Among Bladder Cancer Patients in 3 Community-based Integrated Health Care Systems.

Kwan ML, Leo MC, Danforth KN, Weinmann S, Lee VS, Munneke JR, Bulkley JE, Rosetti MO, Yi DK, Banegas MP, Wagner MD, Williams SG, Aaronson DS, Grant M, Krouse RS, Gilbert SM, McMullen CK.

Urology. 2019 Mar;125:222-229. doi: 10.1016/j.urology.2018.09.037. Epub 2018 Nov 22.

PMID:
30471370
14.

Breast Cancer Outcomes in a Racially and Ethnically Diverse Cohort of Insured Women.

Haque R, Xu X, Shi J, Kwan ML, Chlebowski RT.

Ethn Dis. 2018 Oct 18;28(4):565-574. doi: 10.18865/ed.28.4.565. eCollection 2018 Fall.

15.

Perioperative Intravesical Chemotherapy for Patients WithNon-Muscle-invasive Bladder Cancer: Understanding the Extent of and Sources of Variation in Guideline-recommended Use.

Check DK, Aaronson DS, Nielsen ME, Lee VS, Ergas IJ, Roh JM, Kushi LH, Tang L, Kwan ML.

Urology. 2019 Feb;124:107-112. doi: 10.1016/j.urology.2018.10.016. Epub 2018 Oct 23.

PMID:
30359712
16.

The deterioration of muscle mass and radiodensity is prognostic of poor survival in stage I-III colorectal cancer: a population-based cohort study (C-SCANS).

Brown JC, Caan BJ, Meyerhardt JA, Weltzien E, Xiao J, Cespedes Feliciano EM, Kroenke CH, Castillo A, Kwan ML, Prado CM.

J Cachexia Sarcopenia Muscle. 2018 Aug;9(4):664-672. doi: 10.1002/jcsm.12305. Epub 2018 May 15.

17.

Lifestyle and nutritional modifiable factors in the prevention and treatment of bladder cancer.

Kwan ML, Garren B, Nielsen ME, Tang L.

Urol Oncol. 2019 Jun;37(6):380-386. doi: 10.1016/j.urolonc.2018.03.019. Epub 2018 Apr 25. Review.

18.

Associations of pre-existing co-morbidities with skeletal muscle mass and radiodensity in patients with non-metastatic colorectal cancer.

Xiao J, Caan BJ, Weltzien E, Cespedes Feliciano EM, Kroenke CH, Meyerhardt JA, Baracos VE, Kwan ML, Castillo AL, Prado CM.

J Cachexia Sarcopenia Muscle. 2018 Aug;9(4):654-663. doi: 10.1002/jcsm.12301. Epub 2018 Apr 19.

19.

Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system.

Kroenke CH, Hershman DL, Gomez SL, Adams SR, Eldridge EH, Kwan ML, Ergas IJ, Kubo A, Kushi LH.

Breast Cancer Res Treat. 2018 Aug;170(3):623-631. doi: 10.1007/s10549-018-4774-2. Epub 2018 Apr 18.

20.

Understanding racial/ethnic differences in breast cancer-related physical well-being: the role of patient-provider interactions.

Check DK, Chawla N, Kwan ML, Pinheiro L, Roh JM, Ergas IJ, Stewart AL, Kolevska T, Ambrosone C, Kushi LH.

Breast Cancer Res Treat. 2018 Aug;170(3):593-603. doi: 10.1007/s10549-018-4776-0. Epub 2018 Apr 5.

21.

Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy.

Kwan ML, Yao S, Laurent CA, Roh JM, Quesenberry CP Jr, Kushi LH, Lo JC.

Breast Cancer Res Treat. 2018 Apr;168(2):523-530. doi: 10.1007/s10549-017-4626-5. Epub 2017 Dec 16.

22.

The Uptake of Human Papillomavirus Vaccination and Its Associated Factors Among Adolescents: A Systematic Review.

Loke AY, Kwan ML, Wong YT, Wong AKY.

J Prim Care Community Health. 2017 Oct;8(4):349-362. doi: 10.1177/2150131917742299. Epub 2017 Nov 21. Review.

23.

Use of iDXA spine scans to evaluate total and visceral abdominal fat.

Bea JW, Hsu CH, Blew RM, Irving AP, Caan BJ, Kwan ML, Abraham I, Going SB.

Am J Hum Biol. 2018 Jan;30(1). doi: 10.1002/ajhb.23057. Epub 2017 Sep 8.

24.

Genetic Ancestry Is not Associated with Breast Cancer Recurrence or Survival in U.S. Latina Women Enrolled in the Kaiser Permanente Pathways Study.

Engmann NJ, Ergas IJ, Yao S, Kwan ML, Roh JM, Ambrosone CB, Kushi LH, Fejerman L.

Cancer Epidemiol Biomarkers Prev. 2017 Sep;26(9):1466-1469. doi: 10.1158/1055-9965.EPI-17-0148.

25.

Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer: Results From the C SCANS Study.

Feliciano EMC, Kroenke CH, Meyerhardt JA, Prado CM, Bradshaw PT, Kwan ML, Xiao J, Alexeeff S, Corley D, Weltzien E, Castillo AL, Caan BJ.

JAMA Oncol. 2017 Dec 1;3(12):e172319. doi: 10.1001/jamaoncol.2017.2319.

26.

Explaining the Obesity Paradox: The Association between Body Composition and Colorectal Cancer Survival (C-SCANS Study).

Caan BJ, Meyerhardt JA, Kroenke CH, Alexeeff S, Xiao J, Weltzien E, Feliciano EC, Castillo AL, Quesenberry CP, Kwan ML, Prado CM.

Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):1008-1015. doi: 10.1158/1055-9965.EPI-17-0200. Epub 2017 May 15.

27.

Patterns and reasons for switching classes of hormonal therapy among women with early-stage breast cancer.

Kwan ML, Roh JM, Laurent CA, Lee J, Tang L, Hershman D, Kushi LH, Yao S.

Cancer Causes Control. 2017 Jun;28(6):557-562. doi: 10.1007/s10552-017-0888-9. Epub 2017 Mar 27.

28.

Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer.

Cespedes Feliciano EM, Kwan ML, Kushi LH, Chen WY, Weltzien EK, Castillo AL, Sweeney C, Bernard PS, Caan BJ.

Cancer. 2017 Jul 1;123(13):2535-2542. doi: 10.1002/cncr.30637. Epub 2017 Mar 13.

29.

Adiposity, post-diagnosis weight change, and risk of cardiovascular events among early-stage breast cancer survivors.

Cespedes Feliciano EM, Kwan ML, Kushi LH, Weltzien EK, Castillo AL, Caan BJ.

Breast Cancer Res Treat. 2017 Apr;162(3):549-557. doi: 10.1007/s10549-017-4133-8. Epub 2017 Feb 7.

30.

Impact of Social and Built Environment Factors on Body Size among Breast Cancer Survivors: The Pathways Study.

Shariff-Marco S, Von Behren J, Reynolds P, Keegan TH, Hertz A, Kwan ML, Roh JM, Thomsen C, Kroenke CH, Ambrosone C, Kushi LH, Gomez SL.

Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):505-515. doi: 10.1158/1055-9965.EPI-16-0932. Epub 2017 Feb 2.

31.

Association of Weight Change after Colorectal Cancer Diagnosis and Outcomes in the Kaiser Permanente Northern California Population.

Meyerhardt JA, Kroenke CH, Prado CM, Kwan ML, Castillo A, Weltzien E, Cespedes Feliciano EM, Xiao J, Caan BJ.

Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):30-37. doi: 10.1158/1055-9965.EPI-16-0145. Epub 2016 Dec 16.

32.

Postdiagnosis social networks and breast cancer mortality in the After Breast Cancer Pooling Project.

Kroenke CH, Michael YL, Poole EM, Kwan ML, Nechuta S, Leas E, Caan BJ, Pierce J, Shu XO, Zheng Y, Chen WY.

Cancer. 2017 Apr 1;123(7):1228-1237. doi: 10.1002/cncr.30440. Epub 2016 Dec 12.

33.

Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis.

Yao S, Zhang Y, Tang L, Roh JM, Laurent CA, Hong CC, Hahn T, Lo JC, Ambrosone CB, Kushi LH, Kwan ML.

Breast Cancer Res Treat. 2017 Feb;161(3):501-513. doi: 10.1007/s10549-016-4068-5. Epub 2016 Dec 3.

34.

Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival: A Case-Cohort Analysis in the Pathways Study.

Yao S, Kwan ML, Ergas IJ, Roh JM, Cheng TD, Hong CC, McCann SE, Tang L, Davis W, Liu S, Quesenberry CP Jr, Lee MM, Ambrosone CB, Kushi LH.

JAMA Oncol. 2017 Mar 1;3(3):351-357. doi: 10.1001/jamaoncol.2016.4188.

35.

BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study.

Greenlee H, Hershman DL, Shi Z, Kwan ML, Ergas IJ, Roh JM, Kushi LH.

J Natl Cancer Inst. 2016 Oct 28;109(2). pii: djw206. Print 2017 Feb.

36.

Metabolic Dysfunction, Obesity, and Survival Among Patients With Early-Stage Colorectal Cancer.

Cespedes Feliciano EM, Kroenke CH, Meyerhardt JA, Prado CM, Bradshaw PT, Dannenberg AJ, Kwan ML, Xiao J, Quesenberry C, Weltzien EK, Castillo AL, Caan BJ.

J Clin Oncol. 2016 Oct 20;34(30):3664-3671. doi: 10.1200/JCO.2016.67.4473.

37.

Exercise and Prognosis on the Basis of Clinicopathologic and Molecular Features in Early-Stage Breast Cancer: The LACE and Pathways Studies.

Jones LW, Kwan ML, Weltzien E, Chandarlapaty S, Sternfeld B, Sweeney C, Bernard PS, Castillo A, Habel LA, Kroenke CH, Langholz BM, Queensberry CP Jr, Dang C, Weigelt B, Kushi LH, Caan BJ.

Cancer Res. 2016 Sep 15;76(18):5415-22. doi: 10.1158/0008-5472.CAN-15-3307. Epub 2016 Aug 3.

38.

Race/ethnicity, genetic ancestry, and breast cancer-related lymphedema in the Pathways Study.

Kwan ML, Yao S, Lee VS, Roh JM, Zhu Q, Ergas IJ, Liu Q, Zhang Y, Kutner SE, Quesenberry CP Jr, Ambrosone CB, Kushi LH.

Breast Cancer Res Treat. 2016 Aug;159(1):119-29. doi: 10.1007/s10549-016-3913-x. Epub 2016 Jul 22.

39.

Dual energy X-ray absorptiometry spine scans to determine abdominal fat in postmenopausal women.

Bea JW, Blew RM, Going SB, Hsu CH, Lee MC, Lee VR, Caan BJ, Kwan ML, Lohman TG.

Am J Hum Biol. 2016 Nov;28(6):918-926. doi: 10.1002/ajhb.22892. Epub 2016 Jul 15.

40.

Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study.

Greenlee H, Neugut AI, Falci L, Hillyer GC, Buono D, Mandelblatt JS, Roh JM, Ergas IJ, Kwan ML, Lee M, Tsai WY, Shi Z, Lamerato L, Kushi LH, Hershman DL.

JAMA Oncol. 2016 Sep 1;2(9):1170-6. doi: 10.1001/jamaoncol.2016.0685.

41.

Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer.

Jones LW, Habel LA, Weltzien E, Castillo A, Gupta D, Kroenke CH, Kwan ML, Quesenberry CP Jr, Scott J, Sternfeld B, Yu A, Kushi LH, Caan BJ.

J Clin Oncol. 2016 Aug 10;34(23):2743-9. doi: 10.1200/JCO.2015.65.6603. Epub 2016 May 23.

42.

The Effect of Patient and Contextual Characteristics on Racial/Ethnic Disparity in Breast Cancer Mortality.

Sposto R, Keegan TH, Vigen C, Kwan ML, Bernstein L, John EM, Cheng I, Yang J, Koo J, Kurian AW, Caan BJ, Lu Y, Monroe KR, Shariff-Marco S, Gomez SL, Wu AH.

Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1064-72. doi: 10.1158/1055-9965.EPI-15-1326. Epub 2016 Apr 26.

43.

Analysis of Body Mass Index and Mortality in Patients With Colorectal Cancer Using Causal Diagrams.

Kroenke CH, Neugebauer R, Meyerhardt J, Prado CM, Weltzien E, Kwan ML, Xiao J, Caan BJ.

JAMA Oncol. 2016 Sep 1;2(9):1137-45. doi: 10.1001/jamaoncol.2016.0732.

44.

Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen.

Kwan ML, Shi JM, Habel LA, Song J, Chung JW, Avila CC, Schottinger JE, Cheetham TC, Fletcher SW, Haque R.

Breast Cancer Res Treat. 2016 Apr;156(2):379-89. doi: 10.1007/s10549-016-3763-6. Epub 2016 Mar 22.

PMID:
27002508
45.

Impact of very low physical activity, BMI, and comorbidities on mortality among breast cancer survivors.

Nelson SH, Marinac CR, Patterson RE, Nechuta SJ, Flatt SW, Caan BJ, Kwan ML, Poole EM, Chen WY, Shu XO, Pierce JP.

Breast Cancer Res Treat. 2016 Feb;155(3):551-7. doi: 10.1007/s10549-016-3694-2. Epub 2016 Feb 10.

46.

Validation of self-reported comorbidity status of breast cancer patients with medical records: the California Breast Cancer Survivorship Consortium (CBCSC).

Vigen C, Kwan ML, John EM, Gomez SL, Keegan TH, Lu Y, Shariff-Marco S, Monroe KR, Kurian AW, Cheng I, Caan BJ, Lee VS, Roh JM, Bernstein L, Sposto R, Wu AH.

Cancer Causes Control. 2016 Mar;27(3):391-401. doi: 10.1007/s10552-016-0715-8. Epub 2016 Jan 21.

47.

Who Gets to Decide?

Smith-Bindman R, Kwan ML, Miglioretti DL.

Radiology. 2016 Feb;278(2):635-6. doi: 10.1148/radiol.2015151682. No abstract available.

PMID:
26789608
48.

Post-diagnosis social networks, and lifestyle and treatment factors in the After Breast Cancer Pooling Project.

Kroenke CH, Michael YL, Shu XO, Poole EM, Kwan ML, Nechuta S, Caan BJ, Pierce JP, Chen WY.

Psychooncology. 2017 Apr;26(4):544-552. doi: 10.1002/pon.4059. Epub 2016 Jan 8.

49.

RE: Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741.

Kwan ML, Quesenberry CP Jr, Caan BJ.

J Natl Cancer Inst. 2016 Jan;108(1). doi: 10.1093/jnci/djv333. No abstract available.

PMID:
26719884
50.

Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer Survivors.

Haque R, Shi J, Schottinger JE, Ahmed SA, Cheetham TC, Chung J, Avila C, Kleinman K, Habel LA, Fletcher SW, Kwan ML.

J Natl Cancer Inst. 2015 Dec 1;108(3). doi: 10.1093/jnci/djv337. Print 2016 Mar.

Supplemental Content

Support Center